checkAd

     121  0 Kommentare AlzeCure Presents New Data on its Preventive Treatment Alzstatin at the Alzheimer's Conference AD/PD 2023 - Seite 3

    AlzeCure presents new data on its preventive treatment Alzstatin at the Alzheimer's conference AD/PD 2023

    Lesen Sie auch

    SOURCE: AlzeCure Pharma



    View source version on accesswire.com:
    https://www.accesswire.com/746172/AlzeCure-Presents-New-Data-on-its-Pr ...


    The AlzeCure Pharma Stock at the time of publication of the news with a fall of -0,28 % to 0,351EUR on Frankfurt stock exchange (28. März 2023, 08:11 Uhr).

    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Accesswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    AlzeCure Presents New Data on its Preventive Treatment Alzstatin at the Alzheimer's Conference AD/PD 2023 - Seite 3 STOCKHOLM, Sweden / ACCESSWIRE / March 28, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer